Differing T-cell requirements for recombinant retrovirus vaccines

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 368-372

  Hasenkrug, Kim J ^a   Brooks, Diane M ^a   Nishio, Jane ^a   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMAL; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHIMERIC PROTEINS; EPITOPES; FEMALE; FRIEND MURINE LEUKEMIA VIRUS; LYMPHOCYTE DEPLETION; MALE; MICE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0029655515     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.368-372.1996     Document Type: Article

References (35)

1. Buller, R. M., K. L. Holmes, A. Hügin, T. N. Frederickson, and H. C. Morse III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells Nature (London) 328:77-79.
2. Cease, K. B. 1994. Toward a vaccine for AIDS, the emergence of immunobiology-based vaccine development. Annu. Rev. Immunol. 12:923-989.
3. Chesebro, B., M. Bloom, K. Wehrly, and J. Nishio. 1979. Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J. Virol 32:832-837.
4. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio. and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
5. Chesebro, B., M. Miyazawa, and W. J. Britt. 1990. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:477-499.
6. Chesebro, B., and K. Wehrly. 1976. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J. Exp. Med. 143:85-99
7. Chesebro, B., and K. Wehrly. 1976. Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies. J Exp. Med. 143:73-84.
8. Chesebro, B., K. Wehrly, D. Doig, and J. Nishio. 1979. Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene. Proc. Natl. Acad Sci USA 76:5784-5788.
9. Chesebro, B., K. Wehrly, and J. Stimpfling. 1974 Host genetic control of recovery from Friend leukemia virus-induced splenomegaly. Mapping of a gene within the major histocornpatibility complex J Exp. Med. 140:1457-1467.
10. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992 Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev. Immunol 10:123-151.
11. Earl, P. L., B. Moss, R. P. Morrison, K. Wehrly, J. Nishio, and B. Chesebro. 1986. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728-731.
12. Iwashiro, M., T. Kondo, T. Shimizu, H. Yamagishi, K. Takahashi, Y. Matsubayashi, T. Masuda, A. Otuka. N. Fujii, A. Ishimoto, M. Miyazawa, M. N. Robertson, B. Chesebro, and K. Kuribayashi. 1993. Multiplicity of virusencoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol. 67:4533-4542.
13. Rabat, D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148:1-42.
14. - helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. J. Exp. Med. 169:457-467
15. Klarnet, J. P., L. A. Matis, D. E. Kern, M. T. Mizuno, D. J. Peace, J. A. Thompson, P. D. Greenberg, and M. A. Cheever. 1987. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. J. Immunol 138:4012-4017.
16. + T cells in resistance to murine AIDS in A/J mice. J. Immunol. 149:1702-1706.
17. + cytotoxic T-cell responses during chronic viral infection. J. Virot. 68:8056-8063.
18. Miyazawa, M., R. Fujisawa, C. Ishihara, Y. A. Takei, T. Shimizu, H. Uenishi, H. Yamagishi, and K. Kuribayashi. 1995. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. J. Immunol. 155:748-758.
19. Miyazawa, M., J. Nishio, and B. Chesebro. 1988. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes. J. Exp Med. 168:1587-1605.
20. Miyazawa, M., J. Nishio, and B. Chesebro. 1992 Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. J. Virol. 66:4497-4507.
21. Morrison, R. P., P. L. Earl, J. Nishio, D. L. Lodmell, B. Moss, and B. Chesebro. 1987. Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (London) 329:729-732.
22. Nash, A. A., A. Jayasuriya. J. Phelan, S. P. Cobbold, H. Waldmann, and T. Prospere. 1987. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825-833.
23. Oliff, A., L. Collins, and C. Mirenda. 1983. Molecular cloning of Friend mink cell focus-inducing virus identification of mink cell focus-inducing virus-like messages in normal and transformed cells. J. Virol. 48:542-546.
24. Oliff, A. I., G. L. Hager, E. H. Chang, E. M. Scolnick, H. W. Chan, and D. R. Lowy. 1980. Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J. Virol. 33:475-486.
25. Oliff, A. I., D. Linemeyer, S. Ruscetti, R. Lowe, D. R. Lowy, and E. M. Scolnick. 1980. Subgenomic fragment of molecularly cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease J. Virol. 35:924-936.
26. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature (London) 370:463-467.
27. + cytotoxic T cell therapy of cytomegalovirus and HIV infection. Curr. Opin. Immunol. 5:484-491.
28. Robertson, M. N., M. Miyazawa, S. Mori, B. Caughey, L. H. Evans, S. F. Hayes, and B. Chesebro. 1991. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and Western blotting. J. Virol. Methods 34:255-271.
29. Robertson, M. N., G. J. Spangrude, K. Hasenkrug, L. Perry, J. Nishio, K. Wehrly, and B. Chesebro. 1992. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:3271-3277.
30. Ruan, K., and F. Lilly. 1991. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic lymphocytes. Virology 181:91-100.
31. Schwartz, D. H. 1994 Potential pitfalls on the road to an effective HIV vaccine. Immunol. Today 15:54-57.
32. Shimizu, T., H. Uenishi, Y. Teramura, M. Iwashiro, K. Kuribayashi, H. Tamamura, N. Fujii, and H. Yamagishi. 1994 Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells. J Virol. 68:7704-7708.
33. Trader, D. H., S. K, Ruscetti, and E. M. Scolnick. 1980. The molecular biology of Friend virus. Biochim Biophys. Acta 605:305-324.
34. Walker, B. D. 1994 The rationale for immunothcrapy in HIV-1 infection. J. Acquired Immune Dene. Syndr. 7(Suppl. 1):S6-S13.
35. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 328:345-348.